bluuebunny/crossref_metadata_2025_split huggingface dataset:
Biological control of the shot-hole disease in flowering cherry tree using antimicrobial compounds produced by Bacillus velezensis 8–2
Authors: Kim Seulbi , Kim Ho Myeong , Yang Jung Eun , Jeong Seul-Gi , Kim Yeong Yeol , Hwang In Min , Yu Nan Hee , Kim Jin-Cheol , Park Hae Woong 
Published: July 2024

Abstract
Background
Effective control of shot-hole disease in flowering cherries is challenging because of multiple causative pathogens (bacteria and fungi). Bacillus species are well-known for their ability to control plant pathogens; therefore, biological control potential of a Bacillus isolate, B. velezensis 8–2, against SH disease on flowering cherry trees was investigated.

Results
This study revealed strong antimicrobial activity of Bacillus velezensis 8–2 against various plant pathogenic bacteria and fungi, particularly focusing on Xanthomonas arboricola pv. pruni (Xap) and Mycosphaerella cerasella (Mc), which cause shot-hole (SH) disease in flowering cherry trees. In vitro assays showed that the fermentation filtrate of B. velezensis 8–2 inhibited bacterial and fungal growth with minimum inhibitory concentrations of 1.25–10% and 2.5–10%, respectively. UPLC-Q–Orbitrap–MS analysis revealed that B. velezensis 8–2 produced antagonistic compounds, including polyketides (difficidin and oxydifficidin) and cyclic lipopeptides (iturin A, fengycin, and surfatin). To enhance antimicrobial activity, fermentation parameters for optimal production of two antibacterial and three antifungal compounds were investigated in a 5 L jar fermenter. By regulating the agitation speed to sustain the state of vegetative cells, the production period was extended by 20 h at 400 rpm, resulting in maximum yields of 86.6 μg/mL for difficidin and 150.0 μg/mL for oxydifficidin within a 72 h fermentation period. In a field trial, a 500-fold diluted 10% suspension concentrate formulation of B. velezensis 8–2 effectively inhibited the development of SH disease, demonstrating 66.6% disease control and a 90.2% disease symptoms reduction.

Conclusions
This is the first report to assess the disease control efficacy of B. velezensis for the biocontrol of SH disease in the field. These results suggest that the application of B. velezensis 8–2 could serve as a practical alternative for managing various bacterial and fungal diseases, including the management of SH disease in flowering cherry trees.

Graphical Abstract
An empirical study of reflection attacks using NetFlow data
Authors: Chuah Edward , Suri Neeraj 
Published: July 2024

AbstractReflection attacks are one of the most intimidating threats organizations face. A reflection attack is a special type of distributed denial-of-service attack that amplifies the amount of malicious traffic by using reflectors and hides the identity of the attacker. Reflection attacks are known to be one of the most common causes of service disruption in large networks. Large networks perform extensive logging of NetFlow data, and parsing this data is an advocated basis for identifying network attacks. We conduct a comprehensive analysis of NetFlow data containing 1.7 billion NetFlow records and identified reflection attacks on the network time protocol (NTP) and NetBIOS servers. We set up three regression models including the Ridge, Elastic Net and LASSO. To the best of our knowledge, there is no work that studied different regression models to understand patterns of reflection attacks in a large network. In this paper, we (a) propose an approach for identifying correlations of reflection attacks, and (b) evaluate the three regression models on real NetFlow data. Our results show that (a) reflection attacks on the NTP servers are not correlated, (b) reflection attacks on the NetBIOS servers are not correlated, (c) the traffic generated by those reflection attacks did not overwhelm the NTP and NetBIOS servers, and (d) the dwell times of reflection attacks on the NTP and NetBIOS servers are too small for predicting reflection attacks on these servers. Our work on reflection attacks identification highlights recommendations that could facilitate better handling of reflection attacks in large networks.
Short-term epileptic seizures prediction based on cepstrum analysis and signal morphology
Authors: Tajadini Bahar , Seydnejad Saeid R. , Rezakhani Soheila 
Published: July 2024

AbstractThis article aims to provide and implement a patient-specific seizure (for Intervention Time (IT) detection) prediction algorithm using non-invasive data to develop warning devices to prevent further patient injury and reduce stress. Employing algorithms with high initial data volume and computations time to increase the accuracy is an important problem in prediction issues. Consequently, reduction of calculations is met by applying only two effective EEG signal channels without manual removal of artifacts by visual inspection as the algorithm’s input. Autoregression (AR) modeling and Cepstrum detect changes due to IT period. We carry out the goal of higher accuracy by increasing sensitivity to interictal epileptiform discharges or artifacts and reduce errors caused by them, taking advantage of the discrete wavelet transform and the comparison of two channels epochs by applying the median filter. Averaging and positive envelope methods are introduced to patient-specific thresholds become more differentiated as soon as possible and can be lead to sooner prediction. We examined this method on a mathematical model of adult epilepsy as well as on 10 patients with EEG data. The results of our experiments confirm that performance of the proposed approach in accuracy and average false prediction rate is superior to other algorithms. Simulation results have been shown the robustness of our proposed method to artifacts and errors, which is a step towards the development of real-time alarm devices by non-invasive techniques.
From tradition to innovation: dadih, the Minangkabau tribe's traditional fermented buffalo milk from Indonesia
Authors: Herlina Vika Tresnadiana , Setiarto R. Haryo Bimo 
Published: July 2024

AbstractDadih, also known as dadiah, is a traditional fermented buffalo milk from Minangkabau tribe in West Sumatra. This product is similar to yogurt, with a smooth and shiny surface, thick-bodied, creamy color and pleasant flavor. Microbes that play a dominant role in dadih fermentation are lactic acid bacteria, which possess several functional features, including antimicrobial, antioxidant, antimutagenic, hypocholesterolemic and immunomodulatory properties. However, traditional dadih production faced numerous challenges that impede its development, including the limitation of buffalo milk production, unstandardized dadih production due to the spontaneous fermentation, safety concerns from the absence of heat treatment, as well as limited shelf-life and consumer acceptance of traditional dadih product. Therefore, it is crucial to improve buffalo cultivation, using different types of milk, and apply pasteurization process in dadih production. Furthermore, innovation in dadih product that is more durable and preferred by consumers can be achieved through the application of various processing and packaging technologies.
Correlations of pathomorphological parameters between lesions at the invasive front and lymph node metastases in colorectal cancer: a retrospective clinical study
Authors: Peng Hui , Zhang Zhifa , Wu Yingjun , Zhu Yalan 
Published: July 2024

Abstract
Background
Lymph node (LN) metastasis is one of the most important indicators to evaluate stage, choose treatment strategy, and predict outcome of colorectal cancer (CRC). The morphological correlation between primary tumors and LN metastases can help predict the incidence of LN metastasis in CRC more accurately and assist with more individualized risk-stratification management decisions.

Methods
A retrospective study was devised with paired tissue specimens from the invasive front of primary tumors and LN metastases in 426 patients after a radial surgery for CRC. According to the presence (N +) or absence (N-) of regional LN metastasis and the number of LN metastases (pN1a/1b/1c/2a/2b), comparisons were performed regarding tumor budding (TB) and poorly-differentiated clusters (PDC). In addition, their correlation with the incidence of LN metastasis and the extent were explored.

Results
The TB and PDC in the invasive front of primary tumors presented significant correlations with the incidence of LN metastasis and the number of LN metastases in CRC (P < 0.001). TB2/3 led to a risk of LN metastasis 6.68-fold higher than TB1, while PDC2/3 resulted in a risk of LN metastasis 8.46-fold higher than PDC1. Additionally, the risk of developing 4 or more LN metastases was 3.08-fold and 2.86-fold higher upon TB2/3 and PDC2/3 than that with TB1 and PDC1, respectively. Moderate positive correlations were found between the invasive front of primary tumors and LN metastases in terms of TB and PDC, respectively.

Conclusions
TB and PDC, at the invasive tumor front are important morphological markers to evaluate LN metastasis in CRC, and they can be employed as reference indicators to assess or predict the potential of LN metastasis in CRC in clinical practice.
Evaluation of nanocellulose-based anthraquinone from marine fungi Penicillium flavidorsum as an alternative therapy for skin wound healing: histopathological and immunohistochemical evidences from a rat model
Authors: Reda Reham , Assar Doaa H. , Al-Hawary Ibrahim I. , Atiba Ayman , Abdelatty Alaa , Althobaiti Norah , Elbialy Zizy I. 
Published: July 2024

Abstract
Background
Wound healing represents a complex clinical challenge, necessitating the selection of appropriate wound dressings to facilitate an efficient healing process. This study aims to explore an effective approach to enhance wound healing by investigating the therapeutic potential of a nanocellulose-based anthraquinone derived from marine fungi.
Forty male Wistar rats were divided into five groups, including a control group and various four treatment groups. The wound healing process was assessed by measuring the wound area at different time points.

Results
The results showed promising outcomes in terms of wound healing progression. The group treated with anthraquinone and nanocellulose demonstrated the most favorable results, with normal epidermal architecture, marked hyperkeratosis, and minimal dermal edema. This study provides comprehensive evidence supporting the efficacy of this novel alternative therapy through histopathological and immunohistochemical analyses conducted on a rat model.

Conclusion
By addressing the limitations associated with conventional wound dressings, our research contributes to the development of innovative strategies for optimizing wound healing outcomes. The findings presented herein underscore the potential of nanocellulose-based anthraquinone as a promising therapeutic option for promoting skin wound healing. Further investigations are warranted to elucidate the underlying mechanisms and establish the clinical viability of this alternative therapy.
Landscape and challenges in economic evaluations of artificial intelligence in healthcare: a systematic review of methodology
Authors: Kastrup Nanna , Holst-Kristensen Annette W. , Valentin Jan B. 
Published: July 2024

Abstract
Background
The potential for artificial intelligence (AI) to transform healthcare cannot be ignored, and the development of AI technologies has increased significantly over the past decade. Furthermore, healthcare systems are under tremendous pressure, and efficient allocation of scarce healthcare resources is vital to ensure value for money. Health economic evaluations (HEEs) can be used to obtain information about cost-effectiveness. The literature acknowledges that the conduct of such evaluations differs between medical technologies (MedTechs) and pharmaceuticals, and poor quality evaluations can provide misleading results. This systematic review seeks to map the evidence on the general methodological quality of HEEs for AI technologies to identify potential areas which can be subject to quality improvements. We used the 35-item checklist by Drummond and Jefferson and four additional checklist domains proposed by Terricone et al. to assess the methodological quality of full HEEs of interventions that include AI.

Results
We identified 29 studies for analysis. The included studies had higher completion scores for items related to study design than for items related to data collection and analysis and interpretation of results. However, none of the studies addressed MedTech-specific items.

Conclusions
There was a concerningly low number of full HEEs relative to the number of AI publications, however the trend is that the number of studies per year is increasing. Mapping the evidence of the methodological quality of HEEs of AI shows a need to improve the quality in particular the use of proxy measures as outcome, reporting, and interpretation of the ICER.
Matched tissue and circulating tumor DNA (ctDNA) analysis in renal cell carcinoma (RCC): Results from a multimodal real-world database.
Authors: McKay Rana R. , Jani Chinmay , Tran Eli , Hockenberry Adam J , Jaeger Ellen B. , Husni Nabil , Stoppler Melissa Conrad , Mercer Jacob , Pal Sumanta Kumar , Agarwal Neeraj , CHOUEIRI Toni K. , Rose Brent S. , Bagrodia Aditya 
Published: July 2024

4533 Background: Next generation sequencing (NGS) of ctDNA can complement tissue NGS and is a non-invasive test that can be conducted serially, with the potential to enhance assessment of spatial and temporal molecular tumor heterogeneity. Here, we investigated mutations in RCC patients from ctDNA and matched tissue genomic profiling. Methods: From the Tempus multimodal database, we retrospectively analyzed de-identified NGS data from patients (pts) with RCC that had dual tissue (Tempus xT, 648 genes) and ctDNA testing (Tempus xF, 105 genes). Pts with matched samples (collected +/- 90 days of one another) were included. Clinical characteristics and select pathogenic somatic short variants (PSSV) and copy number variants [(amplifications and deletions, two copy number losses (CNL)] were evaluated. Concordance analyses were restricted to the 105 genes tested on the ctDNA panel and further restricted to short variants, with the exception of amplifications and CNL detected by both xF and xT. Results: Among all pts (n=393), the median age was 61 years and 71% were male. Median time from tissue to blood collection was 21 days (IQR, 7, 39). 67% (n=265) and 68% (n=266) had metastatic disease at the time of tissue and blood collection, respectively. The most common tissue sites were kidney (49%, n=189), bone (11%, n=43), lung (9%, n=34), lymph node (8%, n=29), liver (6%, n=23), and brain/CNS (4%, n=17). Genes harboring the most common PSSV in tissue included VHL (59% n=232), PBRM1 (31%, n=123), SETD2 (23%, n=91), and TP53 (14%, n=54). Genes with common PSSV in ctDNA included TP53 (23%, n=91), VHL (18%, n=69), BAP1 (6%, n=23), and PBRM1 (5%, n=21). The combination of tissue and ctDNA testing increased detection of mutations (Table). There was higher concordance between somatic alterations in select genes among patients with metastases. Conclusions: This analysis shows that ctDNA profiling is complementary to tissue based NGS in RCC and can increase the detection of mutations. Concordance between ctDNA and tissue profiling increased in individuals with metastatic disease. Future research is warranted to understand how longitudinal ctDNA analysis can define biomarkers of response and resistance at the mutation and ctDNA fraction levels. [Table: see text]
Belzutifan in patients with advanced clear cell renal cellcarcinoma (ccRCC): Subgroup analysis of the phase 2 LITESPARK-013 study.
Authors: Atkins Michael B. , Ghatalia Pooja , Merchan Jaime R. , George Saby , Haanen John , Gurney Howard , Ravilla Rahul , Van Der Veldt Astrid Aplonia Maria , Beuselinck Benoit , Pokataev Ilya , Suelmann Britt , Tuthill Mark H. , Vaena Daniel A. , Zagouri Flora , Lin Jianxin , Perini Rodolfo F. , Liu Yanfang , Brugarolas James , Agarwal Neeraj 
Published: July 2024

4534 Background: In the randomized phase 2 LITESPARK-013 study (NCT04489771), the first-in-class HIF-2α inhibitor belzutifan showed comparable antitumor activity in patients with pretreated advanced ccRCC at 200 mg and 120 mg doses (objective response rate [ORR]: 23.1% vs 23.7%; 1-sided P= 0.5312). We present results of a post hoc analysis of the pooled population (200 mg and 120 mg arms) across patient subgroups based on prior therapy and IMDC risk group. Methods: Patients with advanced ccRCC, measurable disease per RECIST v1.1, a Karnofsky Performance Scale score of ≥70%, ≤3 prior systemic regimens for advanced ccRCC (including an anti–PD-(L)1 regimen), and disease progression during or after an anti–PD-(L)1 regimen were randomly assigned 1:1 to receive belzutifan 200 mg or 120 mg QD. End points in the pooled population and subgroups were ORR and duration of response per RECIST v1.1 by blinded independent central review. Data cutoff was February 10, 2023. Results: A total of 154 patients were enrolled (200 mg, n = 78; 120 mg, n = 76). In the pooled population, the median age was 64.0 years, 127 patients (82.5%) had intermediate/poor risk per IMDC criteria, 110 patients (71.4%) received 1-3 prior tyrosine kinase inhibitor (TKI) regimens, and 81 patients (52.6%) received 2 or 3 prior lines of therapy. As of the data cutoff date, 39 patients (25.3%) in the pooled population remained on treatment. Median follow-up was 20.1 months (range, 14.8-28.4). In the pooled population, ORR was 23.4% (95% CI, 16.9-30.9; 4 complete responses [CRs], 32 partial responses [PRs]) and median duration of response (DOR) was 16.1 months (range, 2.1+ to 23.5+). Additional efficacy analyses for subgroups are presented in the table. Conclusions: This post hoc analysis from the LITESPARK-013 study of patients with pretreated advanced ccRCC suggests that belzutifan has antitumor activity regardless of prior lines of therapies and prognostic risk category. These results further support belzutifan as a treatment option for advanced RCC. Clinical trial information: NCT04489771 . [Table: see text]
Age and other criteria influencing nontreatment of patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a physician survey in five European countries (Eu5).
Authors: Gupta Shilpa , Powles Thomas , Kearney Mairead , Panattoni Laura , Land Natalie , Flottemesch Thomas , Sullivan Patrick , Kirker Melissa , Bharmal Murtuza , Guenther Silke , Costa Nuno , Grande Enrique 
Published: July 2024

4570 Background: Real-world studies have shown that a majority of pts with la/mUC do not receive first-line (1L) systemic therapy (tx), despite guideline recommendations. This cross-sectional study assessed the criteria that Eu5 physicians consider when making decisions about 1L tx for pts with la/mUC. Methods: A quantitative online survey of Eu5 physicians was performed in Aug-Sep 2022. Respondents answered questions related to demographics, practice patterns, and criteria considered in 1L decision-making. Descriptive statistics were used to analyze demographics and responses. Logistic regression was used to analyze physician characteristics associated with reporting no age threshold vs any age threshold when defining platinum ineligibility. Results: 503 physicians (69% oncologists and 31% urologists) completed the quota-based survey. Most respondents had been in practice for >10 years (69%) and treated 5-19 pts with la/mUC per month (58%) in public teaching hospitals (40%), public nonteaching hospitals (24%), and private hospitals (20%). Physicians estimated that they do not prescribe 1L tx for ≈25% of their pts. The majority of physicians selected advanced age (62.0%) and poor performance status (PS; 54.7%) as their top reasons for not prescribing 1L tx, followed by pt refusal (45.9%) and poor renal function (43.1%). Most physicians (78.1%) reported having an age threshold above which they recommend against 1L systemic tx (mean, 74.7 years old [Table]). After adjusting for baseline characteristics, physicians were more likely to have an age threshold if they were from Italy vs Germany (odds ratio [OR] 0.22 [95% CI 0.06-0.73]), practiced in a public nonteaching hospital (OR 0.28 [95% CI 0.10-0.73]) or public/private office settings (OR 0.14 [95% CI 0.03-0.57]) vs private hospital, and if they treated <20 pts/month (2-10 pts: OR 0.36 [95% CI, 0.17-0.74]; 11-19 pts: OR 0.25 [95% CI 0.09-0.62]). Conclusions: 1L systemic tx rates self-reported by Eu5 physicians were higher than those previously published. Many physicians reported having an age threshold for not offering systemic tx, which was relatively low compared with the senior age profile of the la/mUC population. Physicians who reported an explicit age threshold may be inappropriately excluding pts from tx; this could be a driver for systemic tx underutilization in la/mUC. [Table: see text]
Quantum delocalization, structural order, and density response of the strongly coupled electron liquid
Authors: Dornheim Tobias , Tolias Panagiotis , Vorberger Jan , Moldabekov Zhandos A. 
Published: July 2024

Abstract
We investigate the impact of electronic correlations and quantum delocalization onto the static structure factor and static density response function of the strongly coupled electron liquid. In contrast to a classical system, the density response of the electron liquid vanishes on small length scales due to quantum delocalization effects, which we rigorously quantify in terms of imaginary-time correlation functions and dynamic Matsubara response functions. This allows us to analyze the interplay of structural order and dynamic quantum effects as it manifests itself in the dynamic Matsubara local field correction. Finally, we identify an effective electronic attraction in the spin-offdiagonal static density response when the wavelength of the perturbation is commensurate with the average interparticle distance.
Secondary Hirata Syndrome in a Neonate: Practical Approach and Management
Authors: Perri Alessandro , Fattore Simona , Sbordone Annamaria , Viti Luca , Pitocco Dario , Vento Giovanni 
Published: July 2024

Abstract
Hirata disease, also known as insulin autoimmune syndrome (IAS), is a rare cause of hypoglycemia, due to the presence of insulin autoantibodies (IAA) in the circulating blood. These antibodies are immunoglobulin G (IgG), making placental transfer to the fetus possible. To our knowledge, no reports of IAS have been previously described in the neonatal population. We present a case report of hypoglycemia due to a secondary IAS in a neonate and discuss the management and treatment of the disease.